Stress-induced reactivation of Epstein-Barr virus in astronauts

NeuroImmunoModulation

Volumn 8, Issue 2, 2000, Pages 51-58

  Stowe, Raymond P ^a   Pierson, Duane L ^b   Feeback, Daniel L ^b   Barrett, Alan D T ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b NASA JOHNSON SPACE CENTER   (United States)

Author keywords

Epstein Barr virus; Herpesvirus; Latent virus reactivation; Microgravity; Spaceflight

Indexed keywords

ADRENALIN; HYDROCORTISONE; VIRUS CAPSID ANTIGEN;

ADRENALIN URINE LEVEL; ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CELL SUBPOPULATION; COSMONAUT; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN EXPERIMENT; HYDROCORTISONE URINE LEVEL; IMMUNE RESPONSE; LEUKOCYTE; MALE; MICROGRAVITY; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; SPACE FLIGHT; STRESS; VIRUS REACTIVATION; VIRUS REPLICATION;

EID: 0033802938     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000026453     Document Type: Article

References (34)

1. Cogoli A, Tschopp A: Lymphocyte reactivity during spaceflight. Immunol Today 1985;6:1.
2. Konstantinova IV, Rykova MP, Lesnyak AT, Antropova EA: Immune changes during long-duration missions. J Leukoc Biol 1993;54:189-201.
3. Leach CS: Biochemical and hematological changes after short-term spaceflight. Microgravity Q 1992;2:69-75.
4. Meehan RT, Neale L, Kraus E, Stuart C, Smith M, Cintron N, Sams C: Alteration in human mononuclear leukocytes following spaceflight. Immunology 1992;76:491-497.
5. Taylor GR, Neale LS, Dardano JR: Immunologic analysis of US Space Shuttle crew members. Aviat Space Environ Med 1986;57:213-217.
6. Taylor GR, Konstantinova I, Sonnenfeld G, Jennings R: Changes in the immune system during and after spaceflight. Adv Space Biol Med 1997;6:1-32.
7. Taylor GR, Janney RP: In vivo testing confirms a blunting of the human cell-mediated immune mechanism during spaceflight. J Leukoc Biol 1992;51:129-132.
8. Stowe RP, Sams CF, Mehta SK, Kaur I, Jones ML, Feeback DL, Pierson DL: Leukocyte subsets and neutrophil function after short-term spaceflight. J LeukocBiol 1999;65:179-186.
9. Pavan-Langston D: Herpes simplex virus ocular infections: Current concepts of acute, latent, and reactivated disease. Trans Am Ophthalmol Soc 1990;88:727-796.
10. Rowe DT, Qu L, Reyes J, Jabbour N, Yunis E, Putnam P, Todo S, Green M: Use of quantitative competitive PCR to measure Epstein-Barr virus genome load in the peripheral blood of pediatric transplant patients with lymphoproliferative disorders. J Clin Microbiol 1997;35: 1612-1615.
11. Jones JF, Katz BZ: Epstein-Barr virus infections in normal and immunocompromised patients; in Glaser R, Jones JF (eds): Herpesvirus Infections. New York, Dekker, 1994, pp 187-226.
12. Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT: Epstein-Barr virus and human disease: Recent advances in diagnoss. Clin Microbiol Rev 1988;1:300-312.
13. Glaser R, Kiecolt-Glaser JK, Speicher CE, Holliday JE: Stress, loneliness, and changes in herpes-virus latency. J Behav Med 1985;8:249-260.
14. Glaser R, Rice J, Sheridan J, Fertel R, Stout J, Speicher C, Pinsky D, Kotur M, Post A, Beck M, Keicolt-Glaser JK: Stress-related immune suppression: Health implications. Brain Behav Immun 1987;1:7-20.
15. Glaser R, Pearson GR, Jones JF, Hillhouse J, Kennedy S, Mao H, Kiecolt-Glaser JK: Stress-related activation of Epstein-Barr virus. Brain Behav Immun 1991;5:219-232.
16. Kasl SV, Evans AS, Niederman JC: Psychosocial risk factors in the development of infectious mononucleosis. Psychosom Med 1979; 41:445-466.
17. Hague T, Amlot PL, Helling N, Thomas JA, Sweny P, Rolles K, Burroughs AK, Prentice HG, Crawford DH: Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol 1998;160:6204-6209.
18. Preiksaitis JK, Diaz-Mitoma F, Mirzayans F, Roberts S, Tyrrell DLJ: Quantitative oropharyngeal Epstein-Barr virus shedding in renal and cardiac transplant recipients: Relationship to immunosuppressive therapy, serologic responses, and the risk of posttransplant lymphoproliferative disorder. J Infect Dis 1992;166: 986-994.
19. Rea D, Fourcade C, Leblond V, Rowe M, Joab I, Edelman L, Bitker M, Gandjbakhch I, Suberbielle C, Farcet J, Raphael M: Patterns of Epstein-Barr virus latent and replicative gene expression in Epstein-Barr virus B cell lymphoproliferative disorders after organ transplantation. Transplantation 1992;58:317-324.
20. Lee DJ, Meehan RT, Robinson C, Mabry TR, Smith MJ: Immune responsiveness and risk of illness in US Air Force Academy cadets during basic cadel training. Aviat Space Environ Med 1992;63:517-523.
21. Tingate TR, Lugg DJ, Muller HK, Stowe RP, Pierson DL: Antarctic isolation: Immune and viral studies. Immun Cell Biol 1997;75:275-283.
22. Crary B, Borysenko M, Sutherland DC, Kutz I, Borysenko JZ, Benson H: Decrease in mitogen responsiveness of mononuclear cells from peripheral blood after epinephrine administration in humans. J Immunol 1983;130:694-697.
23. Davis JM, Albert JD, Tracy KJ, Calvano SE, Shires GT, Yurt RW: Increased neutrophil mobilization and decreased chemotaxis during cortisol and epinephrine infusions. J Trauma 1991;31:725-731.
24. Deitch EA, Bridges RM: Stress hormones modulate neutrophil and lymphocyte activity in vitro. J Trauma 1987;27:1146-1154.
25. Dhabhar FS, McEwen BS: Stress-induced enhancement of antigen-specific cell-mediated immunity. J Immunol 1996;156:2608-2615.
26. Fauci AS, Dale DC, Balow JE: Glucocorticosteroid therapy: Mechanisms of action and clinical considerations. Ann Intern Med 1976;84: 304-315.
27. Payne DA, Mehta SK, Tyring SK, Stowe RP, Pierson DL: Incidence of Epstein-Barr virus in astronaut saliva during spaceflight. Aviat Space Environ Med 1999;70:1121-1123.
28. Leach CS, Alfrey CP, Suki WN, Leonard JI, Rambaut PC, Innere DL, Smith SM, Lane HW, Kraus JM: Regulation of body fluid compartments during short-term spaceflight. J Appl Physiol 1996;81:105-116.
29. Stein TP, Schluter MD: Excretion of IL-6 by astronauts during spaceflight. Am J Physiol 1994;266:E448-E452.
30. Glaser R, Kutz LA, MacCallum RC, Malarkey WB: Hormonal modulation of Epstein-Barr virus replication. Neuroendocrinology 1995;62: 356-361.
31. Schuster C, Chasserot-Golaz S, Beck G: Activation of Epstein-Barr virus promoters by a growth-factor and a glucocorticoid. FEBS Lett 1991;284:82-86.
32. Kiecolt-Glaser JK, Malarkey, WB, Chee M, Newton T, Cacioppo JT, Mao HY, Glaser R: Negative behavior during martial conflict is associated with immunological down-regulation. Psychosom Med 1993;55:395-409.
33. Kiecolt-Glaser JK, Newton T, Cacioppo JT, MacCallum RC, Glaser R, Malarkey, WB: Martial conflict and endocrine function: Are men really more physiologically affected than women. J Consul Clin Psychol 1996;64:324-332.
34. Malarkey WB, Kiecolt-Glaser JK, Pearl D, Glaser R: Hostile behavior during martial conflict alters pituitary and adrenal hormones. Psychosom Med 1994;56:41-51.